Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Semiconductor device and manufacturing method
Mobile terminal based on W-CDMA system having receive diversity function and system thereof
Methods and systems for assessing sales activity of a merchant
Frequency offset estimation apparatus and method of OFDM system
Method and system for shared high speed cache in SAS switches
Charge pump and method of biasing deep N-well in charge pump
Biological information monitoring system
  Randomly Featured Patents
Method and receiver implemented on the rake principle
Head moving type electric razor
Quick release device with biasing unit
Single driver connecting structure for an electric bed or chair
Expandable fluoropolymer device for delivery of therapeutic agents and method of making
Semi-active heave compensation system for marine vessels
Method and system balancing resources and claims into retirement
Process for the synthesis of azobenzene compounds having a cyano group in one or both of the ortho positions of the diazo component radical
Rocking chair
Cooling pack